Blood test shows high accuracy in detecting stage I non-small cell lung cancer

Abstract Background In a previous study (Goebel et. al, Cancer Genomics Proteomics 16:229-244, 2019), we identified 33 biomarkers for an early stage (I-II) Non-Small Cell Lung Cancer (NSCLC) test with 90% accuracy, 80.3% sensitivity, and 95.4% specificity. For the current study, we used a narrowed e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cherylle Goebel, Christopher L. Louden, Robert Mckenna, Osita Onugha, Andrew Wachtel, Thomas Long
Format: Artigo
Idioma:Inglês
Publicat: BMC 2020-02-01
Col·lecció:BMC Cancer
Matèries:
Immunoassay
Early stage lung cancer
Detection
Biomarkers
Proteomics
Diagnostic tests
Accés en línia:http://link.springer.com/article/10.1186/s12885-020-6625-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars